GlassScriptPhysician profile
Sean P Conroy
NPI 1902893027
$14,995.83
in general payments reported to CMS, 2019-2025
48 companies · $1,033 in 2025
The $1,033 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,981 · 2020: $554 · 2021: $600 · 2022: $2,355 · 2023: $3,481 · 2024: $3,991 · 2025: $1,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,324 · Education: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,324.10 |
| Education | $181.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,392.11 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $1,853.96 | 2019-2025 | Vraylar, Qulipta, Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $1,126.10 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $947.15 | 2019-2025 | Xifaxan, Cycloset |
| Lilly USA, LLC | $921.51 | 2019-2024 | Mounjaro, Trulicity, Zepbound |
| Glaxosmithkline, LLC. | $815.91 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $812.03 | 2022-2025 | |
| Pfizer INC. | $779.94 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $697.05 | 2019-2025 | Jardiance, Spevigo, Tradjenta |
| Amgen INC. | $584.38 | 2019-2025 | Repatha, Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $409.37 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $360.92 | 2019-2025 | Trintellix |
| Astellas Pharma US INC | $338.63 | 2019-2025 | Veozah, Myrbetriq |
| Janssen Pharmaceuticals, INC | $308.91 | 2019-2024 | Xarelto |
| Esperion Therapeutics, INC. | $204.76 | 2023-2025 | Nexletol |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $196.35 | 2023-2025 | Auvelity |
| Merck Sharp & Dohme LLC | $189.34 | 2019-2020 | |
| Amarin Pharma, INC. | $164.82 | 2019-2020 | |
| Exact Sciences Corporation | $136.87 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $136.09 | 2019-2023 | |
| Abbott Laboratories | $117.25 | 2022-2023 | Freestyle Libre 2 |
| Teva Pharmaceuticals USA, INC. | $108.84 | 2019-2023 | Austedo Xr, Austedo |
| Kowa Pharmaceuticals America, INC. | $106.23 | 2020-2025 | Zoryve, Seglentis, Livalo |
| Otsuka America Pharmaceutical, INC. | $102.51 | 2023-2024 | Rexulti |
| Idorsia Pharmaceuticals US INC | $100.68 | 2022-2023 | Quviviq |
| Sun Pharmaceutical Industries INC. | $99.99 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $92.77 | 2022 | |
| Dexcom, INC. | $85.63 | 2023-2025 | Dexcom G6 Transmitter |
| Bausch Health US, LLC | $82.49 | 2023-2025 | Wellbutrin, Aplenzin |
| E.R. Squibb & Sons, L.L.C. | $78.41 | 2019-2025 | Camzyos, Eliquis |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $76.81 | 2024-2025 | Caplyta |
| Gilead Sciences, INC. | $69.81 | 2019-2022 | |
| Tolmar, INC. | $54.18 | 2023-2025 | Jatenzo |
| Allergan, INC. | $47.64 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $46.88 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $41.89 | 2019 | |
| Leo Pharma INC. | $37.20 | 2024-2025 | Adbry |
| Inspire Medical Systems, INC. | $35.83 | 2024-2025 | Inspire |
| Currax Pharmaceuticals LLC | $34.87 | 2022 | |
| Arcutis Biotherapeutics, INC. | $32.03 | 2025 | Zoryve |
| Inari Medical, INC. | $28.79 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Phathom Pharmaceuticals, INC. | $28.43 | 2024 | Voquezna |
| Genentech USA, INC. | $27.46 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $21.14 | 2024 | Keveyis |
| Almatica Pharma LLC | $18.93 | 2024 | Loreev Xr |
| Evofem Biosciences, INC. | $16.55 | 2022 | |
| Eisai INC. | $14.24 | 2019 | |
| Medtronic Minimed, INC. | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Conroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.